Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis von Distler, J. H. W., Akhmetshina, A., Schett, G., Distler, O.

Volltext

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells von Distler, J H W, Allanore, Y, Avouac, J, Giacomelli, R, Guiducci, S, Moritz, F, Akhmetshina, A, Walker, U A, Gabrielli, A, Müller-Ladner, U, Tyndall, A, Matucci-Cerinic, M, Distler, O

Volltext

The release of microparticles by apoptotic cells and their effects on macrophages von Distler, J H W, Huber, L C, Hueber, A J, Reich, 3rd, C F, Gay, S, Distler, O, Pisetsky, D S

Volltext

Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies von Distler, J H W, Distler, O

Volltext

Angiogenesis and vasculogenesis in systemic sclerosis von Distler, J H W, Gay, S, Distler, O

Volltext

Imatinib as a novel therapeutic approach for fibrotic disorders von Distler, J. H. W., Distler, O.

Volltext

Autologous hematopoietic stem cell transplantation for systemic sclerosis Position statement of the stem cell therapy working party of the German Society of Rheumatology von Alexander, T., Henes, J., Distler, J. H. W., Schmalzing, M., Blank, N., Koetter, Hiepe, F.

Volltext

THU0055 The Nuclear Receptor Vitamin D Receptor Regulates TGF-ß Signaling and Fibroblast Activation in Systemic Sclerosis von Zerr, P., Vollath, S., Palumbo-Zerr, K., Tomcik, M., Distler, A., Beyer, C., Dees, C., Distler, O., Schett, G., Distler, J. H.

Volltext

Criteria to select molecular targets for anti-fibrotic therapy von Distler, J. H. W., Distler, O.

Volltext

THU0057 Inhibition of Heat Shock Protein 90 (Hsp90) Prevents Fibrosis by Targeting Canonical TGF-B Signaling von Tomcik, M., Zerr, P., Pitkowski, J., Palumbo-Zerr, K., Avouac, J., Distler, O., Becvar, R., Haslbeck, M., Senolt, L., Schett, G., Distler, J. H.

Volltext

A3.8 Increased plasma soluble urokinase plasminogen activator receptor level in systemic sclerosis with impaired microvascular abnormalities and fibrosis von Legány, N, Toldi, G, Distler, JH, Beyer, C, Szalay, S, Kovács, L, Vásárhelyi, B, Balog, A

Volltext

Common German language nomenclature for systemic sclerosis von Aringer, M, Müller-Ladner, U, Burkhardt, H, Distler, J H W, Distler, O, Graninger, W B, Günther, C, Hunzelmann, N, Kiener, H, Sticherling, M, Sunderkötter, C, Walker, U A, Riemekasten, G

Volltext

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis von Dees, Clara, Tomcik, Michal, Zerr, Pawel, Akhmetshina, Alfiya, Horn, Angelika, Palumbo, Katrin, Beyer, Christian, Zwerina, Jochen, Distler, Oliver, Schett, Georg, Distler, Jörg H W

Volltext

Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment von Bruni, Cosimo, Heidenreich, Sebastian, Duenas, Ashley, Hoffmann-Vold, Anna-Maria, Gabrielli, Armando, Allanore, Yannick, Chatelus, Emmanuel, Distler, Jörg H W, Hachulla, Eric, Hsu, Vivien M, Hunzelmann, Nicolas, Khanna, Dinesh, Truchetet, Marie-Elise, Walker, Ulrich A, Alves, Margarida, Schoof, Nils, Saketkoo, Lesley Ann, Distler, Oliver

Volltext

The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis von Palumbo, Katrin, Zerr, Pawel, Tomcik, Michal, Vollath, Stefan, Dees, Clara, Akhmetshina, Alfiya, Avouac, Jerome, Yaniv, Moshe, Distler, Oliver, Schett, Georg, Distler, Jörg H W

Volltext

Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database von Sandmeier, Bettina, Jäger, Veronika K, Nagy, Gabriella, Carreira, Patricia E, Tzankov, Alexandar, Widuchowska, Malgorzata, Antic, Milos, Distler, Oliver, Reichert, Helena, Distler, Jörg H W, Walker, Ulrich A, Hügle, Thomas

Volltext

Angiogenesis. Possibilities for therapeutic intervention in rheumatic diseases von Maurer, B, Distler, J H W, Moritz, F, Gay, S, Distler, O

Volltext

Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus von Weber, Christian K., Haslbeck, Martin, Englbrecht, Matthias, Sehnert, Bettina, Mielenz, Dirk, Graef, Daniela, Distler, Jörg H., Mueller, Ruediger B., Burkhardt, Harald, Schett, Georg, Voll, Reinhard E., Fürnrohr, Barbara G.

Volltext

Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect? von Distler, Jörg H W, Distler, Oliver

Volltext

Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies von Distler, J H W, Distler, O

Volltext